TrialAlimentary pharmacology & therapeutics2025

Effects of Resmetirom on Metabolic-Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon-Like Peptide-1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the MAESTRO-NASH Trial.

Mazen Noureddin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.